166 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Elicio Therapeutics Competitors or Alternatives

Elicio Therapeutics's top competitors include Amgen, BioNTech and BridgeBio.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Elicio Therapeutics's company profile

Robert Connelly

CEO

87/100
23
$229.2M
$2.3M
  • $229.2M
    $2.3M
  • 23
    $229.2M
  • $2.3M
  • 87/100
  • 23
  • $229.2M
  • $2.3M
View ProfileView
1
Elicio Therapeutics's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

68/100
25,200
$4.1B
$38.1B
  • $4.1B
    $38.1B
  • 25,200
    $4.1B
  • $38.1B
  • 68/100
  • 25,200
  • $4.1B
  • $38.1B
View ProfileView
2
Elicio Therapeutics's Competitor - BioNTech logo

Ugur Shain

Co-Founder & CEO

90/100
6,946
$1.8B
$3.4B
  • $1.8B
    $3.4B
  • 6,946
    $1.8B
  • $3.4B
  • 90/100
  • 6,946
  • $1.8B
  • $3.4B
View ProfileView
3
Elicio Therapeutics's Competitor - BridgeBio logo

Neil Kumar

Co-Founder & CEO

82/100
400
$5.7B
$713.1M
  • $5.7B
    $713.1M
  • 400
    $5.7B
  • $713.1M
  • 82/100
  • 400
  • $5.7B
  • $713.1M
View ProfileView
4
Elicio Therapeutics's Competitor - Lilly logo

David A Ricks

Chairman & CEO

91/100
39,000
$6.7B
$79.7B
  • $6.7B
    $79.7B
  • 39,000
    $6.7B
  • $79.7B
  • 91/100
  • 39,000
  • $6.7B
  • $79.7B
View ProfileView
5
Elicio Therapeutics's Competitor - Gritstone Bio logo

Andrew Allen

President & CEO

90/100
231
$554.7M
$14.6M
  • $554.7M
    $14.6M
  • 231
    $554.7M
  • $14.6M
  • 90/100
  • 231
  • $554.7M
  • $14.6M
View ProfileView
Elicio Therapeutics' top 15 competitors are Amgen, BioNTech, BridgeBio, Boehringer Ingelheim, Lilly, Gritstone Bio, Hookipa Pharma, Roche, Revolution Medicines, Novartis, Merck, Apellis, Jacobio Pharma, Cognition Therapeutics and Dianomi Therapeutics, Inc.. Together they have raised over 53.1B between their estimated 376.0K employees. Elicio Therapeutics has 23 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 23,500.

Elicio Therapeutics VS Amgen

Amgen is perceived as one of Elicio Therapeutics's biggest rivals. Amgen's headquarters is in Thousand Oaks, California, and was founded in 1980. Amgen operates in the Pharmaceuticals industry. Amgen generates 1,655,584% of Elicio Therapeutics's revenue.

Elicio Therapeutics VS BioNTech

BioNTech has been one of Elicio Therapeutics's top competitors. BioNTech is a Public company that was founded in 2008 in Mainz, Rhineland-Palatinate. BioNTech operates in the Biotechnology industry. Compared to Elicio Therapeutics, BioNTech has 6,923 more employees.

Looking for similar companies to Elicio Therapeutics?

Similar Companies

Biotechnology companies in Boston

See 267 companies 
Biotechnology companies in Greater Boston

See 1,267 companies 
Pharmaceuticals & Biotechnology companies in Boston

See 339 companies 
Biotechnology companies in Massachusetts

See 1,342 companies 
Pharmaceuticals & Biotechnology companies in Greater Boston

See 1,629 companies 
Pharmaceuticals & Biotechnology companies in Massachusetts

See 1,722 companies 
Companies in Boston with revenue in $100K-5.0M range

See 3,373 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,523 companies 
Biotechnology companies with employees in 25-100 range

See 5,171 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Elicio Therapeutics and Elicio Therapeutics's Competitors

September 2, 2026Yahoo
THOUSAND OAKS, Calif., Sept. 2, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 2026 Wells Fargo Healthcare Conference at 11:00 a.m. ET o...
September 2, 2026Nasdaq
Key PointsBioNTech has not performed well in recent years, as its COVID-19 portfolio has struggled....
September 2, 2026European Biotechnology
Roche has licensed Simcere Zaiming's preclinical trispecific antibody SIM0660, paying $75 million (€65 million) upfront in a deal potentially worth $1....

Frequently Asked Questions about Elicio Therapeutics

  1. Who are Elicio Therapeutics's top competitors?

    Elicio Therapeutics's top 3 competitors are Amgen, BioNTech, BridgeBio.

  2. Who is similar to Elicio Therapeutics?

    Amgen is the most similar to Elicio Therapeutics. BioNTech and BridgeBio are also similar to Elicio Therapeutics.

  1. Are Elicio Therapeutics and Amgen competitors?

    Yes, Amgen is one of Elicio Therapeutics’s top competitors.